Doxorubicin (DX)-treated mice represent an animal model for studying new drugs for heart disease. Coincidentally, in the collection of damaged myocardial tissue, thrombosis was detected in the atrium. The incidence reached 75% in mice given 4 mg/kg DX iv 10 times. They were white thrombi consisting of the fibrin, platelets, and neutrophils. Cardiac muscle damage was more prominent in the atria than in the ventricles. Light microscopically, vacuolization and degeneration of atrial myocytes and interstitial inflammatory cell infiltration were observed. Electron microscopy revealed dilatation of the sarcoplasmic reticulum and an increase in number of normal and/or degenerate mitochondria. Inflammation extended from the cardiac muscle to the endocardium. The cause of atrial thrombosis in DX-treated mice is unknown but may relate to endocardia1 damage and changes of blood flow in the atrium secondary to cardiac muscle damage. DX-treated mice could serve as an experimental animal model for the evaluation of efficacy and toxicity of antithrombotic or antiplatelet drugs.
INTRODUCTION
Doxorubicin (DX), an anthracycline antibiotic, plays a significant role in the treatment of cancer (10, 1 I). However, this substance causes cardiac muscle damage dose-dependently at high cumulative doses (6) . When we prepared a cardiac muscle model (a small-animal model) for the development of new cardiac drugs by administering DX to mice, we found that atrial thrombosis occurred incidentally at a high incidence, unlike the spontadeous. disease, which is low (4, 15, 18) . The purpose of this study was to clarify the pathogenesis of atrial thrombosis caused by DX and to investigate the potential of DX-treated mice to serve as an experimental animal model for the development of new --tith*qmbotic or antiplatelet drugs.
METHODS
Male ICR mice at the age of 6 wk were purchased from' SLC, Inc. (Shizuoka, Japan). After quarantine for 7 days, the animals weighing 3 1-35 g at the start of the study were allocated to 3 groups of 12 males each (Table I) and were allowed free access to food (ME Oriental Yeast Co., Ltd., Tokyo, Japan) and tap water throughout the study. The animals were housed 4 to a plastic cage with chips in the animal toom in the barrier system. Room temperature and humidity wkre 22 f 2°C and 55 f 5%, respectively. The room was daily lighted from 7:OO AM to 7:OO PM by a timer. Adequate consideration was taken so that unnecessary anxiety or pain was not given to the animals. Animal care and use procedures were in accordance with "Guideline for Animal Experimentation" (8) .
DX hydrochloride dissolved in saline was injected into the lateral tail vein of animals at a dose of 2 or 4 mglkg of body weight. One group served as controls and were injected iv only with saline. 362 Based on the previous report (I), dose levels were set at 4 mg/kg (causing marked cardiac damage) and 2 mg/kg (causing mild cardiac damage). Mice were given DX or saline on Tuesday and Friday in weeks 1, 2, 5, 6, and 7 (total: 10 times). The animals were observed daily for clinical signs to toxicity. Body weight of each animal was recorded just before the start of dosing and once a week during the study. The animals were euthanized under deep ether anesthesia after collecting blood from the abdominal aorta during week I 1. The serum was separated from the samples, and albumin, GOT, GPT, and creatinine were measured. At necropsy, the organs and tissues were macroscopically examined after blood collection, and the heart, liver, and kidneys were removed and fixed in 10% buffered formalin. The heart was cut longitudinally to examine all the atria and ventricles of both sides in a single section. Routine parafin sections (3 pm) of these organs were stained with H&E and phosphotungstic acid hematoxylin (PTAH) and examined by light microscopy. In addition, the heart was examined also by electron microscopy. The atria that had been immersed in 10% buffered formalin were cut into small pieces and fixed with 1% osmium tetroxide buffered with 0.1 M, pH 7.3 phosphate. The tissue blocks were embedded in Epon after dehydration with ethanol. Semithin sections (500 nm) were stained with toluidine blue. Ultrathin sections (40 nm) were stained with uranyl acetate and lead citrate and examined with a JEM-100SX electron microscope (JEOL Ltd., Tokyo).
RESULTS

General Signs
Although decreased spontaneous motility and re; spiratory distress were observed in the 4-mg/kg DX group after week 5 of the study, no animals died in any group throughout the study.
Body Weight
The increases in group mean body weight ( Fig. 1 and Table 11 ) were similar in the saline, 2-mg/kg DX, and 4-mg/kg DX groups from weeks 1-5. However, body weight decreased slightly and transiently in week 7 in the 2-mg/kg group and markedly from week 5 onward in the 4-mg/kg group. There were r -a-Dx2mgkg clear-cut differences in body weight between the individual mice with and without atrial thrombosis (Table 11 ). The decreased ratc of body weight in animals with thrombosis from week 5 onward was not less than 10% (10-27o/q), but that of the animals without thrombosis was not more than 4% (1.8-3.4%).
Blood Chemistry
No significant changes in clinical chemistry parameters were observed in the saline or 2-mglkg group (Table 111 ). GOT and GPT increased in the 4-mg/kg DX group though not significantly. GOT and GPT increases correlated with myocardial and/ or liver cell damage, which was confirmed histopathologically.
Gross Pathology
Gross pathological findings are summarized in Table IV . No abnormal findings were observed in the saline group. Only bilateral testicular atrophy was observed in the 2-mg/kg DX group. Left atrial enlargement was observed in 8 of 12 mice in the 4-mg/kg group. Right atrial enlargement was also observed in 2 of these 8 animals. The atrium was filled with soft white mass (Fig. 2) . Furthermore, pleural effusion, ascites, and subcutaneous edema were observed in these mice with cardiac failure.
Histopathology
Histopathological findings are summarized in Table V.
Heart. No abnormal findings were observed in the saline group. There was no thrombosis though vacuolization of the myocytes, and slight interstitial fibrosis was observed in a few animals of the 2-mg/ kg group. Left atrial thrombosis was observed in 9 mice (8 by gross inspection and 1 histopathologically) in the 4-mg/kg DX group. Right atrial thrombosis was observed in 2 of these 9 animals with left atrial thrombosis. Histologically, these were white thrombi; fibrin and platelets aggregated and some neutrophils were present in these thrombi. They were stained royal purple by the PTAH staining method (Fig. 3) . Fibroblasts and capillaries invaded the mar-ginal area of the thrombi from the inner wall of the atrium. Vacuolization and degeneration of atrial myocytes, interstitial inflammatory cell infiltration, and fibrosis were observed (Fig. 4) . The inflammation extended from the cardiac muscle to the endocardium. Endocardial endothelium showed eosinophilic changes of the cytoplasm and pyknosis of the nucleus. An inflammatory cell infiltration and slight fibrosis were observed in the subendothelial stroma. The inflammatory changes of the atrium were more prominent than those of the ventricle. On electron microscopic examination of the atrial myocytes, there were vacuoles resembling dilated sarcoplasmic reticulum, thickened irregular Z-bands ( Fig. 5) , an increase in number of lysosomes and degenerated mitochondria (Fig. 6) , disappearance of myofibril, and myolysis of the myocardial cells.
Liver and Kidneys. No abnormal changes were observed in the saline or 2-mg/kg DX group. In the 4-mg/kg DX group, vacuolization of hepatocytes with concomitant karyomegaly and inflammatory cell infiltration were observed. Protein casts and basophilic tubules were observed in the kidneys. Although the PTAH staining preparations were examined in detail, microthrombi were not observed in either organ.
DISCUSSION
The occurrence of atrial thrombosis, synonymously called auricular thrombosis, has been reported in several laboratory animals: dogs (7, 9) , rats (4, 1 S), and mice (5, 12, 15) . The highest incidence of spontaneous atrial thrombosis reported was 66% in retired breeding BALB/c female mice (12) . To the contrary, the incidence in the BALB/c virgin females and males was 1% or less (5, 15) . As for chemically induced thrombosis, 4-aminobiphenyl (14) and DX (16) are known as causative compounds.
The pathogenesis of the thrombosis has been thought to be related to 3 factors: (a) changes in the intima of the vessel, atrium, or ventricle, (b) abnormal blood Bow, and (c) changes in blood coagulation factors (17) . In the present study, the thrombosis was related to the endocardia1 inflammation and abnormal blood flow (whirlpool) in the atrium secondary to myocardial damage. Atrial thrombosis in humans can occur in association with cardiac infarction, and abnormal blood flow (whirlpool) ip the atrium (13) facilitates this process. Since blood coagulation tests were not performed in the present study, it is uncertain whether or not there were any changes in blood coagulation factors. However, the involvement of abnormal coagulation factors is unlikely because (a) abnormalities of blood coagulation factors have not been reported in animals given DX (2) and (b) no thrombi were observed in the renal glomeruli or hepatic sinusoids in the present study. In this context, Solcia et a1 (16) , who first reported atrial thrombosis in mice given DX, considered the endocardial changes to be the main factor for causing atrial thrombosis, based on the findings that thickening and desquamation of the endocardium occurred along the affected atrium. In the present study, however, the endocardial thickening and desquamation were not observed, and the endocardial damage seemed due to inflammation of the cardiac muscle.
As for the abnormalities of the blood coagulation factors, it is interesting that, in the retired breeding BALBk female mice already cited, a rebound of plasma prothrombin of 20-25% above the normal after parturition may be related to the production of the atrial thrombosis (1 2). In 4-aminobiphenylinduced thrombosis, it is suspected that the thrombosis is related to the toxic effect of this compound on the hematopoietic system, since extramedullary erythropoiesis and hemosiderosis were observed in the spleen (14).
The high incidence of the atrial thrombosis in the present study may be related to the experimental design. It appears that an intermittent dosing (twice a week) with a pause in weeks 3 and 4 gradually damaged the cardiac muscle but did not produce a rapid and fatal change, as caused by continuous dosing. Consequently, progressive myocardial damage resulted in mild sustained changes in blood flow and intimal damage to the atrium, leading to thrombus formation.
It is of vital importance for the development of new antithrombotic or antiplatelet drugs that animal models be selected that enable evaluation for efficacy and safety (3) . The incidence of left atrial thrombosis was high (75%), and marked body weight loss was observed in animals with thrombosis in the present study. The body weight increased up to 5 wk of dosing but, thereafter, decreased in the 4-mg/ kg DX group. There were distinct differences in body weight between the animals with and without atrial thrombosis in this group. Sedation, labored breathing, and subcutaneous edema have been reported in mice with atrial thrombosis (12) . In the present study, respiratory distress, decreased spontaneous motility, and subcutaneous edema were prominent. Thus, mice with thrombosis are easily distinguished fromthose without thrombosis by the indices of body weight loss and clinical signs. It is suggested that mice with DX-induced thrombosis can be used as an animal model for evaluating lysis and prevention of thrombosis and for screening potential fibrinolytic compounds.
